Description
PF-06939999 is a SAM-competitve inhibitor of PRMT5.
| Product Unit Size | Cost | Quantity | Stock |
|---|
PF-06939999 is a SAM-competitve inhibitor of PRMT5.
| Cas No. | 2159123-14-3 |
|---|---|
| Purity | ≥98% |
| Formula | C22H23F3N4O3 |
| Formula Wt. | 448.45 |
| IUPAC Name | (1S,2S,3S,5R)-3-[[6-(difluoromethyl)-5-fluoro-1,2,3,4-tetrahydroisoquinolin-8-yl]oxy]-5-(4-methylpyrrolo[2,3-d]pyrimidin-7-yl)cyclopentane-1,2-diol |
| Synonym | PF06939999; PRMT5-IN-3 |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Jensen-Pergakes K, Tatlock J, Maegley K, et al. SAM-competitive PRMT5 inhibitor PF-06939999 demonstrates antitumor activity in splicing dysregulated NSCLC with decreased liability of drug resistance. Mol Cancer Ther. 2022 Jan;21(1):3-15. PMID 34737197
Immunodominant peptide fragment of PLP, used to...
Micronuclei formation inducer, antimitotic, oxi...
FIASMA; α1- and β1/2-adrenergic antagonist.
Anthracycline, DNA intercalator; topoisomerase ...
Staurosporine analog; PKC and PKA inhibitor.
Steroid; glucocorticoid agonist.
Acyclic nucleotide (adenosine) analog; viral DN...
Endogenous bombesin-like peptide, involved in f...
MGMT inhibitor.
Corticosteroid
SYK/JAK inhibitor
TRPC5, NS4B, histamine H1 inhibitor.
Fluoroquinolone, optically active isomer of ofl...
Tamoxifen analog; SERM.
Synthesis impurity
Fluoroquinolone; topoisomerase IV and bacterial...
Alkaloid originally found in species of Nicotia...
Ca2+ ionophore.
Fluorouracil impurity
CDK1/2 inhibitor.